CD40LG and cancer: However, after treatment with TP5 combined with WSAA, the levels of IgG/IgM in the sera of the model groups were significantly increased/decreased compared to those of the model group, suggesting that WSAA–TP5 treatments could effectively enhance antitumor capacities in H22 tumor-bearing mice while suppressing cancer cell quantities.